Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 28, 2023 12:59pm
Bolsonaro living in the USA
https://www.bloomberg.com/news/articles/2023-01-28/jair-bolsonaro-s-son-dismisses-idea-of-father-s-extradition-back-to-brazil-by-us?srnd=premium
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 28, 2023 9:53am
RE:RE:RE:RE:RE:Cheap Valuation
Mayby mugs/alises head deep in the sand should travel to latam to undestand what a fool he/she/the is. A business model for profit and excustions that work well mosy oof the times
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 28, 2023 9:07am
RE:RE:RE:RE:Cheap Valuation
Well said Longrun - lots there - lots to do in making this a success. It just takes time to become popular with markets. In this industry it's even harder to get people excited. Probably why some
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 28, 2023 8:38am
RE:RE:RE:RE:Cheap Valuation
Long you contunue to ignore the fact, cheap generic drug and latam on fire. Now i Latam all governamets are leftist. Latam high inflation and currencies devaluations. Latam is chaotic economic
...more
(154)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Jan 27, 2023 1:22pm
RE:RE:RE:Cheap Valuation
Hi folks, For individual investors, time is one of the only advantages we really have compared to institutions. I can sit here and look at the share price do nothing for a while just as long as the
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 27, 2023 12:39pm
More good news for Argentina and Brazil
https://www.ft.com/content/59cc26b3-d9fa-48f1-bdd5-fd4c83bc13ee
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 27, 2023 8:15am
RE:RE:Cheap Valuation
Absolutely. Eventually it will react but betting on "when" has always proven to be a losing bet. It's a name that isn't really known. It isn't interesting or exciting (drug
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 27, 2023 5:47am
RE:RE:Cheap Valuation
For ten Years plus deals GUD's share price has reacted alright...!! the wrong and undesirable direction. What else could change if the multi Skippers of a sinking sail boat remain the same
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Jan 27, 2023 2:19am
RE:Cheap Valuation
In reality, it's impossible to say when the share price reacts. But strong numbers, new deals... if these take place, the share price will eventually react, and that's what matters. Hopefully
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 26, 2023 8:26pm
RE:Cheap Valuation
Current enviroment good? insane statement. I wil help. Go to Google, type for each country "Peru Hoy" than "Argentina hoy" etc this is spanish, For Brazil type " Brazil
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 26, 2023 7:13pm
Cheap Valuation
Trevor Rose’s Insights - Trades at a cheap valuation. Investors’ patience has run out. Recent acquisition gave it a new life. Current environment can be favorable. --------------- Cheap valuation
...more
(3)
•••
Spirou25
X
View Profile
View Bullboard History
Comment by
Spirou25
on Jan 26, 2023 1:28pm
RE:RE:RE:Eli Lilly drug was rejected
all the info is on sedar. Go read a little bit. Profit has been gud on this drug.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 25, 2023 2:09pm
RE:RE:RE:Eli Lilly drug was rejected
As you all can see mad losing fortunes mugsy will never answears the hard inconvinent questions though he know best. Yep he knows how to lose forture thogh I think he/she/it buys one share at the time
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 25, 2023 11:29am
RE:RE:Eli Lilly drug was rejected
Sales...what sales? I aks you again? What is GUD profits for the Alzheimer drug gud bought for over 200 million?
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >